Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001826466-24-000136
Filing Date
2024-11-01
Accepted
2024-11-01 13:21:57
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A form-10qa.htm   iXBRL 10-Q/A 375950
2 EXHIBIT-31.1 exhibit31-1.htm EX-31.1 7152
3 EXHIBIT-32.1 exhibit32-1.htm EX-32.1 3227
  Complete submission text file 0001826466-24-000136.txt   2352262

Data Files

Seq Description Document Type Size
4 XBRL CALCULATION FILE nkph-20240630_cal.xml EX-101.CAL 31695
5 XBRL DEFINITION FILE nkph-20240630_def.xml EX-101.DEF 81311
6 XBRL LABEL FILE nkph-20240630_lab.xml EX-101.LAB 176561
7 XBRL PRESENTATION FILE nkph-20240630_pre.xml EX-101.PRE 153944
8 XBRL SCHEMA FILE nkph-20240630.xsd EX-101.SCH 19996
51 EXTRACTED XBRL INSTANCE DOCUMENT form-10qa_htm.xml XML 206003
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56234 | Film No.: 241418265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)